1. Hepatocyte-specific PPAP2B ablation increases plasma levels of several minor pro-atherogenic lipid species and worsens atherosclerosis in apoE-/- MICE. (September 2016) Authors: Busnelli, M.; Manzini, S.; Hilvo, M.; Parolini, C.; Ganzetti, G.S.; Dellera, F.; Ekroos, K.; Jänis, M.; Sirtori, C.R.; Laaksonen, R.; Chiesa, G. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lipidomics of plasma, liver and aorta of Pcsk9-KO mice. (September 2016) Authors: Chiesa, G.; Busnelli, M.; Parolini, C.; Manzini, S.; Ganzetti, G.S.; Dellera, F.; Suoniemi, M.; Hilvo, M.; Hurme, R.; Ekroos, K.; Sirtori, C.R.; Laaksonen, R. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Plasma ceramides identify residual cardiovascular risk in statin treated coronary artery disease patients. (September 2016) Authors: Laaksonen, R.; Ekroos, K.; Sysi-Aho, M.; Vihervaara, T.; Kauhanen, D.; Hilvo, M.; Hurme, R.; Pedersen, E. Ringdal; Tell, G.; Nygård, O. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗